Can therapy help pregnant women stay on HIV prevention? new study aims to find out.

NCT ID NCT05624931

First seen Jun 25, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This study tests a short counseling program (about 4 sessions) designed to help pregnant and postpartum women in Cape Town, South Africa, keep taking their daily HIV-prevention pill (PrEP). Many women stop PrEP due to depression or trauma from violence. The program uses cognitive behavioral therapy (CBT) to improve coping and build healthy habits. Researchers will enroll 118 women to see if the program is feasible and acceptable, and whether it helps them stay on PrEP during pregnancy and after birth.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Brief CBT-based behavioral intervention
What this could lead to
If it works, this could point toward a practical, low-cost way to help pregnant women at high HIV risk stay on PrEP by treating underlying depression and trauma.
What could go wrong
This is a small, early-stage pilot study (118 participants) testing feasibility and acceptability, not effectiveness. The intervention is still being developed, so results may not generalize or show clear benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Boston University

    NOT_YET_RECRUITING

    Boston, Massachusetts, 02215, United States

  • Gugulethu Midwife Obstetric Unit (MOU)

    RECRUITING

    Cape Town, Western Cape, 8001, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.